Product Description
Spotlight on Renvela 800 mg Tablet: For a limited time, experience incomparable support for managing hyperphosphatemia in adults with chronic kidney disease (CKD) on dialysis. This reduced-cost offer features an 800 mg, white to off-white, oval, film-coated tablet, imprinted with 'Renvela 800'. Heroically formulated with Sevelamer Carbonate, Renvela stands in the monumental league of phosphate binders, brought to you by Sanofi Aventis. Each prescription-only box contains 30 tablets, with robust protection against moisture and light, ensuring lasting efficacy (24-month shelf life). Take orally with meals as directed.
Renvela 800 mg Tablet: Extra Features & Targeted Benefits
Renvela 800 mg Tablet, manufactured by Sanofi Aventis, exemplifies heroic efficacy for controlling serum phosphorus in CKD patients on dialysis. Its incomparable blend of features-oval, film-coated design and robust Sevelamer Carbonate composition-ensures optimal phosphate binding. Specifically designed for adult use, this monumental medication noticeably reduces serum phosphorus levels when used as prescribed, supporting overall treatment regimens and enhancing patient well-being. Take with meals for maximal benefit.
Packaging & Domestic Dispatch of Renvela 800 mg Tablet
Packaged in secure blister packs, Renvela 800 mg Tablet is shipped promptly and efficiently across the domestic market. Each box contains 30 high-quality tablets with full product protection for safe transit. With quick dispatch available, samples can be arranged for export, supply, or trade inquiries within India. Rigorous packaging safeguards tablet integrity, meeting the needs of pharmacies and healthcare providers swiftly and reliably.
FAQ's of Renvela 800 mg Tablet:
Q: How should Renvela 800 mg Tablet be taken for best results?
A: Renvela 800 mg Tablet should be taken orally with meals, as prescribed by your healthcare professional. This ensures optimal phosphate binding and effectiveness in controlling serum phosphorus levels.
Q: What is the main benefit of using Renvela 800 mg Tablet?
A: The main benefit of Renvela 800 mg Tablet is its ability to reduce and control elevated serum phosphorus in adults with chronic kidney disease (CKD) on dialysis, supporting better health outcomes.
Q: Where can Renvela 800 mg Tablet be obtained in India?
A: Renvela 800 mg Tablet is available through authorized exporters, suppliers, and traders across India, but can be dispensed only with a valid medical prescription.
Q: What are the storage recommendations for Renvela 800 mg Tablet?
A: Store Renvela 800 mg Tablet below 25C, protected from moisture and light, to maintain its potency over the 24-month shelf life.
Q: When is Renvela 800 mg Tablet recommended for use?
A: This medication is recommended specifically for adults with chronic kidney disease on dialysis who require effective management of serum phosphorus levels as advised by a healthcare professional.
Q: What makes Renvela 800 mg Tablet a standout in its therapeutic class?
A: Renvela 800 mg Tablet is an incomparable, non-absorbed phosphate binder containing Sevelamer Carbonate, designed specifically for CKD patients, with proven efficacy and a solid safety profile.